CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing therapeutic antibodies to neutralize immunogenic gluten peptides for individuals with celiac disease who struggle with a gluten-free diet. By creating improved versions of these antibodies, the project aims to enhance treatment options and diagnostic capabilities for affected patients…
Celiac disease affects about 1% of the population worldwide.
It is an autoimmune disease triggered by gluten intake in genetically predisposed individuals.
Celiac disease causes intestinal villi atrophy that results in a deficient absorption of nutrients and other risks.
Gluten major sources are wheat, rye, barley and some oats.
Currently, the only effective treatment is a permanent gluten free diet (GFD).
However, a fully GFD is difficult to achieve.
The average daily gluten intake in celiac pa…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
